Nurix Therapeutics Inc Development Under Stress - Finding New Ubiquitylation Enzymes for Therapeutic Benefit Transcript
Okay, we're zooming past 50 people. So [Micha], maybe we'll go ahead and get started.
©, -
Let's go, Jennifer.
Okay, great. Well, hi, everybody. It's an incredible pleasure to be able to introduce my Berkeley colleague, Michael Rapé to you today. And I wanted to tell you a little bit about Michael's background. So he's been a member of the Berkeley faculty since 2006. He's currently the Peter Hirth Chair of Cancer Biology and an investigator of the Howard Hughes Medical Institute.
And before coming to Berkeley, he was a graduate student at the Max Planck Institute in Martinsried followed by working as a postdoctoral scholar with Marc Kirschner at Harvard Medical School. And he's had a longstanding interest in quality control, especially quality control of proteins and understanding cell-fate
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |